The use of psychotropic drugs in epilepsy

What every neurologist should know

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Psychiatric disorders, such as mood, anxiety, attention deficit, and psychotic disorders, are among the most frequent comorbidities experienced by patients with epilepsy. While these psychiatric disorders have typically been considered as one of its complications, there is increasing evidence of a bidirectional relationship between the seizure disorder and mood and ADHD. Indeed, not only are patients with epilepsy at greater risk of developing these two disorders, but patients with mood and attention deficit disorders are at greater risk of developing epilepsy. Comorbid psychiatric disorders have a negative impact on the quality of life of patients with epilepsy. For patients with pharmacoresistant epilepsy, mood disorders are a stronger predictor of a worse perception of their quality of life than is their seizure frequency and severity. Thus, the use of psychotropic drugs is often necessary in patients with epilepsy, be they children or adults. Unfortunately, there are many misconceptions regarding the safety of psychotropic drugs, particularly of antidepressants and central nervous system stimulants, which are often erroneously thought of as being "proconvulsant." Such misconceptions have resulted in the undertreatment of psychiatric comorbidities in patients with epilepsy. This article provides a practical review of the use of antidepressants, central nervous system stimulants, and antipsychotic drugs in patients with epilepsy.

Original languageEnglish (US)
Pages (from-to)379-388
Number of pages10
JournalSeminars in Neurology
Volume28
Issue number3
DOIs
StatePublished - Jul 2008
Externally publishedYes

Fingerprint

Psychotropic Drugs
Epilepsy
Psychiatry
Central Nervous System Stimulants
Attention Deficit Disorder with Hyperactivity
Antidepressive Agents
Comorbidity
Quality of Life
Central Nervous System Agents
Neurologists
Mood Disorders
Psychotic Disorders
Antipsychotic Agents
Seizures
Anxiety
Safety

Keywords

  • Antipsychotic drugs
  • Attention deficit disorders
  • Central nervous system stimulants
  • Mood disorders
  • Selective serotonin-reuptake inhibitors

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

The use of psychotropic drugs in epilepsy : What every neurologist should know. / Kanner, Andres M.

In: Seminars in Neurology, Vol. 28, No. 3, 07.2008, p. 379-388.

Research output: Contribution to journalArticle

@article{98c00e08745a44f3a458d0db2a7fc4a6,
title = "The use of psychotropic drugs in epilepsy: What every neurologist should know",
abstract = "Psychiatric disorders, such as mood, anxiety, attention deficit, and psychotic disorders, are among the most frequent comorbidities experienced by patients with epilepsy. While these psychiatric disorders have typically been considered as one of its complications, there is increasing evidence of a bidirectional relationship between the seizure disorder and mood and ADHD. Indeed, not only are patients with epilepsy at greater risk of developing these two disorders, but patients with mood and attention deficit disorders are at greater risk of developing epilepsy. Comorbid psychiatric disorders have a negative impact on the quality of life of patients with epilepsy. For patients with pharmacoresistant epilepsy, mood disorders are a stronger predictor of a worse perception of their quality of life than is their seizure frequency and severity. Thus, the use of psychotropic drugs is often necessary in patients with epilepsy, be they children or adults. Unfortunately, there are many misconceptions regarding the safety of psychotropic drugs, particularly of antidepressants and central nervous system stimulants, which are often erroneously thought of as being {"}proconvulsant.{"} Such misconceptions have resulted in the undertreatment of psychiatric comorbidities in patients with epilepsy. This article provides a practical review of the use of antidepressants, central nervous system stimulants, and antipsychotic drugs in patients with epilepsy.",
keywords = "Antipsychotic drugs, Attention deficit disorders, Central nervous system stimulants, Mood disorders, Selective serotonin-reuptake inhibitors",
author = "Kanner, {Andres M}",
year = "2008",
month = "7",
doi = "10.1055/s-2008-1079342",
language = "English (US)",
volume = "28",
pages = "379--388",
journal = "Seminars in Neurology",
issn = "0271-8235",
publisher = "Thieme Medical Publishers",
number = "3",

}

TY - JOUR

T1 - The use of psychotropic drugs in epilepsy

T2 - What every neurologist should know

AU - Kanner, Andres M

PY - 2008/7

Y1 - 2008/7

N2 - Psychiatric disorders, such as mood, anxiety, attention deficit, and psychotic disorders, are among the most frequent comorbidities experienced by patients with epilepsy. While these psychiatric disorders have typically been considered as one of its complications, there is increasing evidence of a bidirectional relationship between the seizure disorder and mood and ADHD. Indeed, not only are patients with epilepsy at greater risk of developing these two disorders, but patients with mood and attention deficit disorders are at greater risk of developing epilepsy. Comorbid psychiatric disorders have a negative impact on the quality of life of patients with epilepsy. For patients with pharmacoresistant epilepsy, mood disorders are a stronger predictor of a worse perception of their quality of life than is their seizure frequency and severity. Thus, the use of psychotropic drugs is often necessary in patients with epilepsy, be they children or adults. Unfortunately, there are many misconceptions regarding the safety of psychotropic drugs, particularly of antidepressants and central nervous system stimulants, which are often erroneously thought of as being "proconvulsant." Such misconceptions have resulted in the undertreatment of psychiatric comorbidities in patients with epilepsy. This article provides a practical review of the use of antidepressants, central nervous system stimulants, and antipsychotic drugs in patients with epilepsy.

AB - Psychiatric disorders, such as mood, anxiety, attention deficit, and psychotic disorders, are among the most frequent comorbidities experienced by patients with epilepsy. While these psychiatric disorders have typically been considered as one of its complications, there is increasing evidence of a bidirectional relationship between the seizure disorder and mood and ADHD. Indeed, not only are patients with epilepsy at greater risk of developing these two disorders, but patients with mood and attention deficit disorders are at greater risk of developing epilepsy. Comorbid psychiatric disorders have a negative impact on the quality of life of patients with epilepsy. For patients with pharmacoresistant epilepsy, mood disorders are a stronger predictor of a worse perception of their quality of life than is their seizure frequency and severity. Thus, the use of psychotropic drugs is often necessary in patients with epilepsy, be they children or adults. Unfortunately, there are many misconceptions regarding the safety of psychotropic drugs, particularly of antidepressants and central nervous system stimulants, which are often erroneously thought of as being "proconvulsant." Such misconceptions have resulted in the undertreatment of psychiatric comorbidities in patients with epilepsy. This article provides a practical review of the use of antidepressants, central nervous system stimulants, and antipsychotic drugs in patients with epilepsy.

KW - Antipsychotic drugs

KW - Attention deficit disorders

KW - Central nervous system stimulants

KW - Mood disorders

KW - Selective serotonin-reuptake inhibitors

UR - http://www.scopus.com/inward/record.url?scp=49149091003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49149091003&partnerID=8YFLogxK

U2 - 10.1055/s-2008-1079342

DO - 10.1055/s-2008-1079342

M3 - Article

VL - 28

SP - 379

EP - 388

JO - Seminars in Neurology

JF - Seminars in Neurology

SN - 0271-8235

IS - 3

ER -